Automated weekly replanning for intensity-modulated radiotherapy of cervix cancer.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 20832664)

Published in Int J Radiat Oncol Biol Phys on October 01, 2010

Authors

James Stewart1, Karen Lim, Valerie Kelly, Jason Xie, Kristy K Brock, Joanne Moseley, Young-Bin Cho, Anthony Fyles, Anna Lundin, Henrik Rehbinder, Johan Löf, David Jaffray, Michael Milosevic

Author Affiliations

1: Princess Margaret Hospital/Ontario Cancer Institute, University Health Network, Toronto, Canada.

Articles by these authors

Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med (2010) 4.63

Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst (2002) 4.33

Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys (2013) 3.56

Cone beam computed tomography image guidance system for a dedicated intracranial radiosurgery treatment unit. Int J Radiat Oncol Biol Phys (2012) 2.03

Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2011) 2.00

Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol (2013) 1.99

Fluence field optimization for noise and dose objectives in CT. Med Phys (2011) 1.93

Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A (2012) 1.80

Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys (2007) 1.77

MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res (2011) 1.75

Assessment of a model-based deformable image registration approach for radiation therapy planning. Int J Radiat Oncol Biol Phys (2007) 1.75

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys (2010) 1.73

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.66

Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity. Clin Cancer Res (2006) 1.65

Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. J Clin Invest (2012) 1.57

Excellence in Radiation Research for the 21st Century (EIRR21): description of an innovative research training program. Int J Radiat Oncol Biol Phys (2012) 1.53

Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy. Mol Ther (2007) 1.48

A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys (2006) 1.46

TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair. Clin Cancer Res (2013) 1.45

Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys (2004) 1.41

Demons deformable registration of CT and cone-beam CT using an iterative intensity matching approach. Med Phys (2011) 1.35

Diffusion-weighted MRI in cervical cancer. Eur Radiol (2008) 1.34

Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys (2003) 1.31

Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys (2007) 1.29

Accurate accumulation of dose for improved understanding of radiation effects in normal tissue. Int J Radiat Oncol Biol Phys (2010) 1.28

Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys (2007) 1.28

5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19). J Clin Oncol (2006) 1.26

Auto-segmentation of normal and target structures in head and neck CT images: a feature-driven model-based approach. Med Phys (2011) 1.24

Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response. Clin Cancer Res (2013) 1.24

The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure. Semin Radiat Oncol (2004) 1.23

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy. Cancer (2012) 1.23

Image-guided radiotherapy: has it influenced patient outcomes? Semin Radiat Oncol (2012) 1.23

Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys (2005) 1.22

Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning. Int J Radiat Oncol Biol Phys (2007) 1.20

Image guided dose escalated prostate radiotherapy: still room to improve. Radiat Oncol (2009) 1.20

Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy. Int J Radiat Oncol Biol Phys (2007) 1.20

Pelvic radiotherapy for cancer of the cervix: is what you plan actually what you deliver? Int J Radiat Oncol Biol Phys (2009) 1.19

On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys (2004) 1.18

Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.18

Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res (2003) 1.17

Adapting population liver motion models for individualized online image-guided therapy. Conf Proc IEEE Eng Med Biol Soc (2008) 1.16

Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies. Future Oncol (2007) 1.15

Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys (2008) 1.12

Inter- and intrafraction variability in liver position in non-breath-hold stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 1.11

Invasive cervical cancer: a failure of screening. Eur J Public Health (2007) 1.10

Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys (2009) 1.09

A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol (2004) 1.09

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate (2009) 1.08

A novel technique to enable experimental validation of deformable dose accumulation. Med Phys (2012) 1.08

Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer. J Magn Reson Imaging (2012) 1.08

Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer (2008) 1.07

Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2004) 1.07

Biomechanical-based image registration for head and neck radiation treatment. Phys Med Biol (2010) 1.06

Assessment of residual error in liver position using kV cone-beam computed tomography for liver cancer high-precision radiation therapy. Int J Radiat Oncol Biol Phys (2006) 1.06

A local shift-variant Fourier model and experimental validation of circular cone-beam computed tomography artifacts. Med Phys (2009) 1.05

Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol (2006) 1.04

Toward efficient biomechanical-based deformable image registration of lungs for image-guided radiotherapy. Phys Med Biol (2011) 1.04

Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol (2006) 1.03

Endometrial cancer risk is associated with variants of the mismatch repair genes MLH1 and MSH2. Cancer Epidemiol Biomarkers Prev (2006) 1.03

Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model. Mol Pharm (2009) 1.03

Interfraction and intrafraction changes in amplitude of breathing motion in stereotactic liver radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.03

Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148. J Clin Oncol (2008) 1.02

Adaptive radiation therapy for compensation of errors in patient setup and treatment delivery. Med Phys (2004) 1.00

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer (2014) 0.99

A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment. Int J Radiat Oncol Biol Phys (2006) 0.98

Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys (2006) 0.98

MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study. Radiology (2010) 0.98

Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3. Clin Cancer Res (2013) 0.98

MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer. PLoS One (2013) 0.98

Dysregulated PTEN-PKB and negative receptor status in human breast cancer. Int J Cancer (2003) 0.98

Quality assurance of serial 3D image registration, fusion, and segmentation. Int J Radiat Oncol Biol Phys (2008) 0.97

A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy. Radiother Oncol (2005) 0.97